MARATTO

article · JAC-Antimicrobial Resistance

Phenotypic and genotypic characterization of <i>Neisseria gonorrhoeae</i> isolates from Ethiopia, 2021 to 2023

2026Open accessBahir Dar University

Abstract

Abstract Objectives Antimicrobial resistance (AMR) in Neisseria gonorrhoeae is increasing globally, but some regions remain understudied. This study aimed to investigate the AMR phenotypes and genotypes of N. gonorrhoeae isolates from Bahir Dar, Ethiopia, and their phylogenetic relationship to global isolates. Methods Endocervical and urethral swabs were collected from symptomatic patients at sexually transmitted infection (STI) clinics from September 2021 to April 2023. The identified N. gonorrhoeae isolates (n = 70) were subjected to AMR phenotyping and WGS. We generated a recombination-corrected phylogeny with 724 global representative isolates and used phylodynamics to estimate the introduction times of isolates into Bahir Dar. Results All isolates were resistant to ciprofloxacin and tetracycline but susceptible to ceftriaxone, cefixime, azithromycin, and spectinomycin (100% susceptibility); 67 (95.7%) were resistant to penicillin. WGS identified 14 MLSTs, with ST-1587 (54.3%) the dominant sequence type. AMR determinants correlated with phenotypic findings for all antimicrobials. The phylogenetic analysis suggested at least nine introductions of N. gonorrhoeae into Bahir Dar. The ST-1587 isolates were introduced recently, showing close genetic ties to global isolates sampled in 2018–2019 from Asia, Europe, North America, and Oceania. ST-7827 displayed greater genetic divergence from global isolates. Conclusions This study presents WGS of N. gonorrhoeae isolates from Ethiopia, uncovering diverse sequence types and multidrug resistance. These findings underscore the need for routine genomic surveillance, improved antimicrobial stewardship, and targeted public health interventions to combat the spread of AMR and improve STI management in Ethiopia.

Research topics

  • Reproductive tract infections research
  • Bacterial Infections and Vaccines
  • Neonatal and Maternal Infections

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1093/jacamr/dlag126

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.